SCHEMBL129396

SCHEMBL129396

OCC1=Cc2cccc3cccc1c23

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
MAPK1 P28482 3/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 7/20 0.40
CES2 O00748 1/20 0.40
BCHE P06276 1/20 0.40
CES1 P23141 1/20 0.40
MCL1 Q07820 1/20 0.40
S100A4 P26447 1/20 0.38
HSD17B10 Q99714 7/20 0.38
TSHR P16473 3/20 0.38
ATM Q13315 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HEXA P06865 1/20 0.37
HEXB P07686 1/20 0.37
RXFP1 Q9HBX9 3/20 0.36
PABPC1 P11940 2/20 0.36
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20495669 0.87 MEN1 (0.56) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL31121101 0.87 MEN1 (0.56) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL129395 0.80 MAPK1 (0.52) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL131338 0.80 MAPK1 (0.47) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL131339 0.80 MAPK1 (0.47) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL130313 0.80 MAPK1 (0.47) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL130314 0.80 MAPK1 (0.47) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL4512216 0.80 MEN1 (0.47) MEN1KMT2AMAPK1MAPTALDH1A1
Hydrochloric Acid SCHEMBL10599412 0.78 MAPK1 (0.46) MEN1KMT2AMAPK1MAPTALDH1A1
SCHEMBL7195529 0.77 MAPK1 (0.44) MEN1KMT2AMAPK1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386904-B1 Acenaphthylene derivative, polymer, and antireflection film-forming composition JSR CORP (JP) 2008-09-17 EP claimed
US-7037994-B2 Acenaphthylene derivative, polymer, and antireflection film-forming composition JSR CORPORATION (JP) 2006-05-02 US claimed
US-20040034155-A1 Acenaphthylene derivative, polymer, and antireflection film-forming composition JSR CORPORATION (JP) 2004-02-19 US claimed
EP-1386904-A1 Acenaphthylene derivative, polymer, and antireflection film-forming composition JSR Corporation (JP) 2004-02-04 EP claimed
US-12572075-B2 Composition, method of forming resist underlayer film, and method of forming resist pattern JSR CORPORATION (JP) 2026-03-10 US disclosed
US-12312487-B2 Method for forming protective film, method for manufacturing patterned substrate, and composition JSR CORPORATION (JP) 2025-05-27 US disclosed
WO-2025018305-A1 METHOD FOR MANUFACTURING MAGNETIC TUNNEL JUNCTION ELEMENT JSR株式会社 2025-01-23 WO disclosed
WO-2024205936-A1 GAS RELEASING UNDERLAYERS FOR PHOTOPATTERNABLE ORGANOMETALLIC RESIST INPRIA CORPORATION (US) 2024-10-03 WO disclosed
US-20240319599-A1 GAS RELEASING UNDERLAYERS FOR PHOTOPATTERNABLE ORGANOMETALLIC RESIST JSR CORPORATION (JP) 2024-09-26 US disclosed
US-20240231231-A1 METHOD FOR FORMING RESIST UNDERLAYER FILM, METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE, COMPOSITION, AND RESIST UNDERLAYER FILM JSR CORPORATION (JP) 2024-07-11 US disclosed
US-20230242787-A1 METHOD FOR FORMING PROTECTIVE FILM, METHOD FOR MANUFACTURING PATTERNED SUBSTRATE, AND COMPOSITION JSR CORPORATION (JP) 2023-08-03 US disclosed
CN-112635292-B Thermal desorption ionization mechanism verification device and application thereof 四川师范大学 2023-06-27 CN disclosed
EP-1510210-A1 IMMUNITY-RELATED PROTEIN KINASE INHIBITORS Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-02 EP disclosed
US-20040259877-A1 Inhibitors against the production and release of inflammatory cytokines INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2004-12-23 US disclosed
US-20040206940-A1 Novel method of preparing nitrogen macrocycles COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2004-10-21 US disclosed
JP-2004168748-A ACENAPHTHYLENE DERIVATIVE, POLYMER, AND ANTIREFLECTION FILM FORMING COMPOSITION JSR CORP 2004-06-17 JP disclosed
US-20040034155-A1 Acenaphthylene derivative, polymer, and antireflection film-forming composition JSR CORPORATION (JP) 2004-02-19 US disclosed
EP-1386904-A1 Acenaphthylene derivative, polymer, and antireflection film-forming composition JSR Corporation (JP) 2004-02-04 EP disclosed
EP-1352650-A1 INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES Institute of Medicinal Molecular Design, Inc. (JP) 2003-10-15 EP disclosed
US-20030073040-A1 Pattern forming method and bilayer film JSR CORPORATION (JP) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12572075-B2 Composition, method of forming resist underlayer film, and method of forming resist pattern TOP1, NAF1, ASH2L MEN1 1539/4885KMT2A 511/4885MAPK1 3188/4885
US-20040259877-A1 Inhibitors against the production and release of inflammatory cytokines NFKBIA, IL1B, IKBKB MEN1 4661/4885KMT2A 4095/4885MAPK1 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.